There are 223 papers on diastolic dysfunction in aging research: 9 trials and 76 observational studies in people, 105 in animals, 2 in cells, 30 reviews. The newest story, Nov 9, 2026: “Heart-filling problems grew more common in very late life”.
Diastolic dysfunction is linked with frailty and higher cardiovascular mortality in human studies of people with preserved ejection fraction, with the mortality association reported in those without valvular disease. In mice with age-dependent dysfunction, rapamycin, caloric restriction and nicotinamide improve diastolic function; DCSL1 prevents dysfunction in aged females but shows no clear effect in aged males.
69 findings in 54 papers from 2006 to 2026, 9 of them since May 2026
“each 1-unit increase in BRI was associated with 14.4% higher odds of DD (OR = 1.144, 95% CI: 1.046-1.251, P = 0.003).”
Nicotinamide decreases diastolic dysfunction in rats (diastolic dysfunction induced by hypertension in Dahl salt-sensitive rats).
“Elevating NAD+ by oral supplementation of its precursor, nicotinamide, improved diastolic dysfunction induced by aging (in 2-year-old C57BL/6J mice), hypertension (in Dahl salt-sensitive rats)”
Animalsdiastolic dysfunction induced by hypertension in Dahl salt-sensitive rats
Atorvastatin protects against diastolic dysfunction in HIV- and ART-treated mice.
“Mice depleted of platelet TGF-β1 or treated with atorvastatin were partially protected from HIV- and ART-induced cardiac fibrosis, steatosis, and diastolic dysfunction.”
Trimethylamine N-oxide increases diastolic dysfunction in mice (intraperitoneal TMAO injection in young mice).
“Starting from 2 months of TMAO treatment, impairment of cardiac diastolic function and progression of cardiac fibrosis were observed alongside the upregulation of senescence marker proteins expression.”
Animalsintraperitoneal TMAO injection in young miceheartfrom 2 months of treatmentmales
advanced age increases diastolic dysfunction in mice (compared with naked mole-rats, which showed no increase).
“Magnetic resonance and ultrasound imaging showed age-dependent increases in cardiac hypertrophy and diastolic dysfunction in mice which were absent in NMRs.”
Animalscompared with naked mole-rats, which showed no increaseheart
PAK1 protects against diastolic dysfunction in mice (shown by knockout in middle-aged female mice).
“Compared to WT controls, middle-aged PAK1-/- female mice demonstrated worsening of cardiac function involving a greater enlargement of the left atrium, ventricular hypertrophy, and diastolic dysfunction.”
Animalsshown by knockout in middle-aged female miceheartfemales
MT1 protects against diastolic dysfunction in mice (aged cardiomyocytes).
“aged myocytes displayed prolonged TR(90), reduced tolerance to high stimulus frequency, and slowed intracellular Ca2+ decay, all of which were nullified by metallothionein”
Controlled attenuation parameter is associated with diastolic dysfunction in humans (adjusted for age and sex, lost after adjustment for waist circumference).
“CAP was independently associated with diastolic dysfunction after adjustment for age and sex, but this association was lost after further adjustment for waist circumference”
Humansadjusted for age and sex, lost after adjustment for waist circumferencen = 73
Diastolic dysfunction is associated with controlled attenuation parameter in patients with MASLD and obesity.
“Markers of hepatic steatosis, including fatty liver index (FLI) and controlled attenuation parameter (CAP), were higher in patients with diastolic dysfunction”
Clonal hematopoiesis of indeterminate potential is associated with diastolic dysfunction in humans (patients undergoing treatment for solid tumors) (Median time to diastolic dysfunction: 17.5 days with CHIP versus 18.0 days without CHIP).
“CHIP was an independent risk factor for diastolic dysfunction (p-value 0.021)”
Humanspatients undergoing treatment for solid tumorsheartn = 236
TET2 is associated with diastolic dysfunction in humans.
“TET2 mutations, in particular, have been consistently linked to diastolic dysfunction and adverse remodeling, especially in patients with high inflammatory burden and cardiometabolic comorbidities.”
ReviewTET2 mutations, especially in patients with high inflammatory burden and cardiometabolic comorbiditiesheart
Physical activity is linked with a higher risk of diastolic dysfunction in humans after adjustment, compared to Group B (4-12 h/week) (OR = 8.246, 95% CI: 2.118-32.096).
“After adjustment, Group C had higher odds of being classified as having diastolic dysfunction than Group B (OR = 8.246; 95% CI: 2.118-32.096; p = 0.002).”
Humansafter adjustment, compared to Group B (4-12 h/week)>12 h/weekn = 84
Triglyceride-glucose waist circumference index is linked with a higher risk of diastolic dysfunction in humans (fully adjusted for demographics, blood pressure, and clinical comorbidities) (OR 1.002, 95% CI: 1.001-1.004).
“TyG-WC was independently associated with an increased risk of DD (OR = 1.002, 95% CI: 1.001-1.004, P < 0.001).”
Humansfully adjusted for demographics, blood pressure, and clinical comorbidities
“uncoupled perfusion and energy metabolism, together with nitric oxide imbalance, can serve as early indicators of diastolic dysfunction and ischemic susceptibility”
The share with heart-filling problems involving elevated pressure rose from 3% to 24% over an average of 13 years.The share with heart-filling problems involving elevated pressure rose from 3% to 24% over an average of 13 years.
Heart-relaxation problems worsened in 6.5%, 8.2% and 8.5% of participants across increasing thirds of an index combining fasting blood sugar and blood fats.Heart-relaxation problems worsened in 6.5%, 8.2% and 8.5% of participants across increasing thirds of an index combining fasting blood sugar and blood fats.
Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.Male rats with heart failure had heart relaxation times of 25.24 milliseconds with the inhibitor, compared with 27.20 milliseconds without it.
Seven-year rates of atrial fibrillation, an irregular heartbeat, were 6.4% in people flagged by an artificial intelligence heart-tracing model, versus 2.1% in those not…Seven-year rates of atrial fibrillation, an irregular heartbeat, were 6.4% in people flagged by an artificial intelligence heart-tracing model, versus 2.1% in those not flagged.
Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.Removing two activin receptor types from certain immune cells lowered a heart-filling pressure index to 31.93, versus 42.99 in heart-failure mice.